ALB and type 2 diabetes mellitus: Participants with CKD (estimated glomerular filtration rate [eGFR] 25–75 ml/min per 1.73 m2; urinary albumin-to-creatinine ratio 200–500 mg/g), with or without type 2 diabetes, were randomized 1:1 to dapagliflozin 10 mg or placebo, once daily.